Clinical Trials Browser

Phase 2 × Hereditary Sensory and Autonomic Neuropathies × binimetinib × Clear all

NCT01320085 2024-01-24

A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma

Phase 2 Completed

183 enrolled 35 charts

Melanoma, Hereditary Sensory and Autonomic Neuropathies